• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.

作者信息

Levine P H, Hoover R

机构信息

Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):515-7.

PMID:1363833
Abstract
摘要

相似文献

1
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.非霍奇金淋巴瘤的新发流行：关于病因因素的当前认知
Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):515-7.
2
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Time trends and pathological classification: a summary.非霍奇金淋巴瘤的新发病趋势：关于病因因素的当前认知。时间趋势及病理分类：综述
Cancer Res. 1992 Oct 1;52(19 Suppl):5570s.
3
[Increasing incidence and mortality of non-Hodgkin lymphomas. An epidemiological review of recent studies on risk factors for non-Hodgkin lymphoma].[非霍奇金淋巴瘤的发病率和死亡率不断上升。关于非霍奇金淋巴瘤危险因素的近期研究的流行病学综述]
Med Klin (Munich). 2001 Feb 15;96(2):87-100. doi: 10.1007/pl00002183.
4
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiologic factors. Proceedings of a workshop. Bethesda, Maryland, October 22-23, 1991.非霍奇金淋巴瘤的新发病趋势：关于病因学因素的当前认识。研讨会论文集。马里兰州贝塞斯达，1991年10月22 - 23日。
Cancer Res. 1992 Oct 1;52(19 Suppl):5425s-574s.
5
An epidemic of non-Hodgkin's lymphoma: comments on time trends, possible etiologies, and the role of pathology.非霍奇金淋巴瘤的流行：关于时间趋势、可能病因及病理学作用的评论
Mod Pathol. 1992 Sep;5(5):481-2.
6
Conclusion/perspective II--National Cancer Institute Workshop on the emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.结论/展望二——美国国立癌症研究所非霍奇金淋巴瘤新发病例研讨会：关于病因因素的现有知识
Cancer Res. 1992 Oct 1;52(19 Suppl):5574s.
7
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Molecular and immunoregulatory mechanisms: a summary.非霍奇金淋巴瘤的新发病趋势：关于病因学因素的现有知识。分子与免疫调节机制：综述
Cancer Res. 1992 Oct 1;52(19 Suppl):5572s.
8
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Research directions and general discussion: a summary.非霍奇金淋巴瘤的新发病趋势：关于病因因素的当前认知。研究方向与总体讨论：综述
Cancer Res. 1992 Oct 1;52(19 Suppl):5571s.
9
Conclusion/perspective I--National Cancer Institute Workshop on the emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.结论/展望I——美国国立癌症研究所非霍奇金淋巴瘤新发病例研讨会：关于病因学因素的现有知识
Cancer Res. 1992 Oct 1;52(19 Suppl):5573s.
10
Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.康涅狄格州女性的月经与生殖因素及非霍奇金淋巴瘤风险
Am J Epidemiol. 2004 Oct 15;160(8):766-73. doi: 10.1093/aje/kwh278.

引用本文的文献

1
Epidemiology and Etiology of Leukemia and Lymphoma.白血病和淋巴瘤的流行病学和病因学。
Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a034819. doi: 10.1101/cshperspect.a034819.
2
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.硼替佐米可预防 MCL 中的阿糖胞苷耐药，其特征在于 dCK 的下调和 SPIB 的上调，导致 NF-κB 活性增高。
BMC Cancer. 2018 Apr 25;18(1):466. doi: 10.1186/s12885-018-4346-1.
3
Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
非霍奇金淋巴瘤患者非黑色素瘤皮肤癌的发病率和复发率增加：明尼苏达州基于罗切斯特流行病学项目的人群研究。
J Am Acad Dermatol. 2015 Feb;72(2):302-9. doi: 10.1016/j.jaad.2014.10.028. Epub 2014 Dec 2.
4
Inflammatory breast cancer clusters: A hypothesis.炎性乳腺癌簇：一种假说。
World J Clin Oncol. 2014 Aug 10;5(3):539-45. doi: 10.5306/wjco.v5.i3.539.
5
Epidemic of non-hodgkin lymphoma in new zealand remains unexplained.新西兰非霍奇金淋巴瘤的流行原因仍不明。
J Cancer Epidemiol. 2014;2014:315378. doi: 10.1155/2014/315378. Epub 2014 Apr 1.
6
Potential effects of CRM1 inhibition in mantle cell lymphoma.CRM1 抑制在套细胞淋巴瘤中的潜在作用。
Chin J Cancer Res. 2012 Dec;24(4):374-87. doi: 10.3978/j.issn.1000-9604.2012.09.05.
7
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.当前对生活方式、环境因素与非霍奇金淋巴瘤风险的认识：流行病学最新进展
J Cancer Epidemiol. 2012;2012:978930. doi: 10.1155/2012/978930. Epub 2012 Sep 12.
8
Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.慢性淋巴细胞白血病和非霍奇金淋巴瘤患者的恶性纤维组织细胞瘤转移增加。
Mayo Clin Proc. 2011 Aug;86(8):738-43. doi: 10.4065/mcp.2010.0720.
9
Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study.绝经后激素替代疗法的使用与非霍奇金淋巴瘤风险：一项基于丹麦人群的队列研究。
Br J Cancer. 2006 May 8;94(9):1339-41. doi: 10.1038/sj.bjc.6603123.